DRKS00014649招募中不适用
GermanVasc-Registry within the IDOMENEO study - IDOMENEO
niversitätsklinikum Hamburg-Eppendorf0 个研究点目标入组 10,000 人开始时间: 2018年5月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Invasive open-surgical (endarterectomy, bypass surgery) or catheter-based endovascular revascularizations of symptomatic peripheral arterial disease
排除标准
- •No informed consent
- •Patient <18 years
研究者
相似试验
招募中
不适用
German SLD-Registry - Characterization of Patients With Steatotic Liver Disease (SLD) in Germany - Phase 1 (Observation of the Natural Course)K76.0Fatty (change of) liver, not elsewhere classifiedDRKS00024354eberstiftungs-GmbH Deutschland10,000
招募中
不适用
German prospective register study for detecting the treatment of gynecological sarcomas in clinical routineeimyosarcomendometrial stromal sarcomaundifferenciated endometrial stroma sarcomC49C54Malignant neoplasm of other connective and soft tissueMalignant neoplasm of corpus uteriDRKS00009240OGGO e.V.1,200
招募中
不适用
The German GNAO1 Registry - Genotype phenotype correlation of GNAO1 associated diseaseG40.4G24.9Other generalized epilepsy and epileptic syndromesDystonia, unspecifiedDRKS00027434niklinik Köln; Klinik und Poliklinik für Kinder- und Jugendmedizin; Sozialpädiatrisches Zentrum;40
招募中
不适用
German Network for Personalized Medicine (DNPM) - EvaluatioPatients with serious, advanced cancer who have undergone guideline-based therapy and patients with rare tumors for which no guideline-based therapy exists were enrolled.DRKS00031622Zentrum für Personalisierte Medizin, Universitätsklinikum Tübingen6,000
招募中
不适用
German prospective registry for patients with chronic myeloid leukemia (CML) previously treated with =2 TKIs switched to another TKI (ASCiminib or ANY ATP-competitive TKI)C92.1Chronic myeloid leukaemia [CML], BCR/ABL-positiveDRKS00032351Ruprecht-Karls-Universität Heidelberg300